Elevance Health, Inc. closed its sale of $600 million aggregate principal amount of its 5.150% Notes due 2029, $1,000 million aggregate principal amount of its 5.375% Notes due 2034, and $1,000 million aggregate principal amount of its 5.650% Notes due 2054.